Mecain Neural (Mepivacaine Hydrochloride)

Mepivacaine works by binding to voltage‑gated sodium channels on nerve membranes and stabilizing them in an inactive state. This blocks the influx of sodium ions required for depolarization, preventing the generation and propagation of action potentials. The result is a localized loss of sensory and, at higher concentrations, motor function.

The dose of Mecain Neural is determined by the prescribing clinician based on the type of procedure, the anatomical site, patient weight, and clinical judgment. Dosing guidelines are provided in the product’s prescribing information, but the exact amount and concentration are individualized for each patient.

Safety data for mepivacaine during pregnancy and lactation are limited. It is classified as a Category C drug in many regions, meaning risk cannot be ruled out. Use only if the potential benefit justifies the potential risk to the fetus or infant, and always under medical supervision.

To order Mecain Neural, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and required import documentation.

Both mepivacaine and lidocaine are amide‑type local anesthetics, but mepivacaine has a slightly longer duration of action and a faster onset in some tissues. Lidocaine is more widely used and has a broader safety record, while mepivacaine may be preferred when a longer block is desired without adding epinephrine.

Mecain Neural should be stored at temperatures below 25 °C, protected from moisture and direct light. Keep the vial in its original packaging until use, and avoid freezing. Inspect the solution for particulate matter or discoloration before administration, and discard any product that appears compromised.

Mecain Neural is administered by a qualified healthcare professional via epidural, infiltration or intradermal injection. The clinician selects the appropriate needle size and technique, aspirates to confirm extravascular placement, and injects the calculated volume slowly while monitoring the patient for any adverse reactions.

Serious risks include systemic toxicity leading to central nervous system symptoms such as seizures, cardiovascular complications like arrhythmias or cardiac arrest, and severe allergic reactions that can progress to anaphylaxis. Immediate recognition and management of these events are essential, and resuscitation equipment should be readily available.

Mecain Neural should be avoided in patients with a known hypersensitivity to mepivacaine or other amide‑type local anesthetics, those with severe cardiac conduction disorders, uncontrolled epilepsy, or significant hepatic impairment without dose adjustment. It is also contraindicated when inadvertent intravascular injection cannot be ruled out.